|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
The User's
handbook for Haematology and Blood Transfusion provides guidance concerning
the use and interpretation of diagnostic laboratory tests and gives advice
on the correct collection of samples and their submission to the laboratory. Dr
K Boyd MD MRCP FRCPath
Location Craigavon
Area Hospital 02838 334444 Phone Numbers
Daisy Hill Hospital Tel: 028302 - 65511
Monday to Friday - 9 am - 5 pm Saturday & Sunday - 9 am - 1pm Some
non-urgent but essential investigations may need to be carried out after
5pm and before midnight as well as over weekends and Public Holidays.
These are performed by the Biomedical Scientist (BMS) on call for emergencies.
It would be appreciated if requests are confined to essential investigations
only and special arrangements are made to ensure that samples are delivered
to the Haematology Laboratory, CAH as early as possible.
Emergency ServiceOutside normal hours and on Public Holidays (ie 'out of hours') an emergency service is available. Requests for an urgent report should be restricted. If you require an urgent report you should inform the appropriate laboratory by telephone and mark the request as urgent. The request will be fast tracked and the result made available on the ward laboratory results programme within one hour. Results are only telephoned to sites with no computer access. For special emergency requests not on the list below contact the BMS on call.Back
to Top
Daisy
Hill Hospital:
The Consultant Haematologists may be contacted through Craigavon Area Hospital Switchboard.
Additional tests from 9am to 1pm on Saturday, Sunday and Public Holidays
Back to Top Haematology
abd Blood Bank request forms are obtained from Customer Services, CAH
- Andrology request forms are obtained from the Haematology lab. Please complete request forms correctly. Without full patient details computers cannot store accurate records and without full clinical details the laboratory cannot make useful comments and may perform inappropriate tests. Please use the addressograph labels where they are available. The ward or clinic and the name of the Consultant /General Practitioner MUST be clearly written on the form. In blood transfusion it is absolutely essential that request forms are fully and correctly completed and the information is checked either verbally with the patient or with the armband details at the time of blood sampling in order to reduce the risk of Life threatening errors. The person who has taken the sample must read and sign the declaration on the back of the form. Follow the SHSCT Blood Transfusion Policy. Essential
information on REQUEST FORM:
Desirable information on request form :
Back
to Top
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| . |
Type
of container |
Colour of Top |
Volume of blood |
Routine test |
| 1 |
EDTA |
Purple |
3ml |
FBP ESR |
| 2 |
Sodium Citrate |
Blue |
4 ml |
Coagulation |
| 3 |
EDTA |
Pink with white insert |
6 ml |
Bood Transfusion |
| 4 |
Lithium Heparin |
Green |
7 ml |
Osmotic fragility |
| 5 |
Dry bottle (clotted sample) |
Red |
7 ml |
Special investigations |
Semen samples
For these please supply patient with a dry Universal container that has been tested and approved by the laboratory.
| Dry universal container | Available from Hospital Stores |
Paediatric samples
Containers with EDTA for FBP and ESR and containers with sodium citrate for coagulation are available; the volume of blood sample required is indicated on the container label. For special tests eg. osmotic fragility or enzyme assays please ask the haematology lab staff for the minimum blood volume required.
| Paediatric FBP, paediatric coagulation sample bottles and paediatric ESR bottles | All obtained from Hospital Stores |
Bone
marrow aspirate and trephine biopsies.
The
sample needles, microscope slides, pathology and haematology request forms
and special sample bottles are available as a 'bone marrow pack' in the
haematology lab. Instructions regarding the equipement required will be
provided by the haematology doctor carrying out the procedure.
Back
to Top
GUIDELINES
FOR PROPER SPECIMEN COLLECTION AND TRANSPORT
The
majority of haematological specimens are collected into vacutainers with
an appropriate anticoagulant. Instruction for the safe use of the vacutainer
system should form part of local operating procedures but should any difficulty
arise advice is available from the Haematology laboratory.
| 1 | Fill container to the mark ; in coagulation studies this is imperative. Mix by gentle inversion. Do not inject blood into the container through a needle or shake violently as this will haemolyse the specimen. |
| 2 | Do not transfer blood from one container to another at any time. |
| 3 | Clearly label the specimen container. |
| 4 | Addressograph labels are not acceptable on blood transfusion samples (tubes). |
Essential information on TRANSFUSION SAMPLE
| 1 | Patient's surname and first name |
| 2 | Date of Birth |
| 3 | Address or hospital unit number or A & E number |
| 4 | Infant samples: Sex is essential |
| 5 | All Cross-matched samples must have a Hospital Unit Number |
The transfusion sample must be labelled beside the patient at the time of sampling by the person taking the sample. The details must be handwritten on the sample bottle, dated and initialled by the person taking the sample. Blood transfusion samples with addressograph labels will not be accepted for analysis.
The information must be checked either verbally with the patient, if fit, or with the details on the armband, and with the details on the transfusion request form.
Read
and sign the declaration on the reverse of the request form if all is
correct.
The above information applies to emergency and routine samples.
Routine samples for pre-transfusion testing must not be sent out of normal working hours.
Essential information on sample bottle for haematology and coagulation tests
| i | Patient's full name |
| ii | Date of birth and / or hospital unit number |
Desirable information on sample bottle for haematology and coagulation tests
| i | date and time of sample |
| ii | destination for report. |
Transport of sample to the laboratory
It is the requesting doctor's responsibility to arrange transport of the sample to the laboratory as soon as possible.
It is essential that samples arrive at the laboratory in a condition suitable for analysis.
Samples for the following tests must reach the laboratory within the time limits detailed below:
| FBC, ESR | 24 hours |
| Reticolocytes, Blood film | 24 hours |
| INR, coagulation screen | 24 hours |
| Blood transfusion | 24 hours |
| Inhibitor screen and lupus anticoagulant | 1 hour |
| LAP score | 1 hour |
Further
details on sample transport requirements for tests arranged in advance
with the laboratory will be supplied by the BMS.
Back
to Top
REASONS FOR REJECTING SPECIMENS
| 1 |
Specimens submitted in an incorrect container. |
| 2 |
Insufficient information on specimen for proper identification |
| 3 |
Insufficient specimen. |
| 4 |
Specimens which have leaked. |
| 5 |
Specimens which are haemolysed or contaminated. |
| 6 |
Anticoagulated samples which are clotted |
| 7 | Samples arriving outside the time limits specified: |
| Blood counts > 48 hours old. |
|
| Coagulation Samples > 24 hours old. |
|
| 8 |
Insufficient information on request form |
| 9 |
Specimen identification not corresponding to that on request form |
| 10 | Blood transfusion sample with addressograph label attached |
IF ANY OF THE ABOVE OCCUR REPEAT SPECIMENS WILL BE NECESSARY IRRESPECTIVE OF THE DEGREE OF URGENCY OF THE REQUEST.
The majority of Haematology requests will be analysed and the results sent to the requesting medical practitioner the same day or within 24 hours.
Results requiring prompt attention in the interest of patient care will be telephoned to the requesting Medical Practitioner/House Officer.
Electronic mailing facilities are available and in use. Any general practice wishing to avail of such facilities should contact the Pathology Services Manager.
Tests
referred to Reference Laboratories have a turnaround time from a few days
to a few weeks depending on the type of investigation. If the results
are required urgently please ring the laboratory.
Details for individual tests are listed in Tests,
Samples & Turnaround Times.
Back
to Top
Information on tests and the
interpretation of results for patients
Patients are advised to ask the Doctor requesting the blood test for an interpretation of the result and information about the test. General information about the blood testing procedure and individual laboratory tests can be accessed online from www.patient.co.uk and www.labtestonline.org.uk. The laboratory staff are not authorised to give results either written or verbally directly to patients.
Information about congenital thrombophilia and antiphosphoslipid syndrome is available from www.thrombosis-chariety.org.uk.
Warfarin packs are obtained from the hospital pharmacy these are given to all new patients who are commenced on warfarin either in the hospital wards of clinics. A DVD on warfarin is available for patients to view in hospital.
Information leaflets about blood transfusion are available in hospital clinics, day units and on the wards. These are to be offered to patients on the first occasion of blood transfusion and thereafter as needed. They are available on the SHSCT intranet site for Haemovigilence and on the CAH intranet site under blood transfusion.
Patients undergoing bone marrow biopsy are given an explanation of the reasons for performing the tests and verbal and written information about the test procedure by the Doctor performing the test. Written informed consent for the procedure is requested. Written information includes a locally produced leaflet which is available from the Mandeville Unit; in addition patients are offered printed information from www.cancerbacup.org.uk.
Information
on semen ananlysis and fertility tests; patients are advised to seek an
explanation for the tests and an interpretation of the results from the
Doctor requesting the test. Instructions on how to obtain the semen sample
are printed on the reverse side of the hospital request form. General
information on Semen Analysis and fertility tests may be obtained from
www.labtestsonline.org.uk.
Back
to Top
Information on tests and interpretation
of results for users of the service.
For
advice on the test required to investigate a clinical problem and for
assistance with the interpretation of general haematology and coagulation
and blood bank problems, please contact a Consultant Haematologist or
their Deputy. Telephone and Bleep numbers of the Consultants and their
secretaries are listed at the front of this Handbook. Out of hours the
contact details of the Consultant Haematologist On Call are available
from the hospital switchboard.
In the event of a blood transfusion reaction or a breach of the transfusion protocols please inform the Haemovigilence Officer Patricia Watt, her contact details are listed at the front of the Handbook.
For
clinical advice and interpretation of Andrology results please contact
a Consultant Obstetrician, Mr Noel Heasley can be contacted through his
secretary, telephone no: 02838612096 or bleep number 1427.
Back
to Top
TEST INFORMATION
ANDROLOGY
Arrangements
for semen analysis must be made in advance with the laboratory.
Investigation of fertility
Seen
samples should be collected after 2-3 days of sexual abstinence, the sample
must be collected by masturbation and ejaculated into a prewarmed, sterile,
universal container. Condoms must not be used for semen collection because
they interfer with sperm viability. Once collected the seminal fluid must
be kept at body temperature and delivered to the Laboratory within 1 hour.
If the patientlives more than 30 minutes travelling time from the Laboratory
the sample must be collected on site, there is a room provided for sample
production.
Results are sent to the requesting medical
officer who will inform the patient.
Samples of semen are required 4 and 4 ½ months post vasectomy to confirm the absence of sperm. If both samples are not clear then further samples should be sent at monthly intervals until two in sequence have an absence of sperm.
Sperm samples should be collected by masturbation in a clean sterile container (condoms may not be used) and may be left at the laboratory between 9am - 4pm, Monday to Friday.
Results
of Post Vascectomy tests are sent to the Surgeon who carried out the operation.
The Surgeon
will write a report to the patient. The laboratory cannot give these or
any other results direct to the patient.
Back
to Top
Full Blood Count
Haemoglobin concentration, red cell indices, white cell count and automated differential white cell count (DWCC) and platelet count.
Normal ranges are wide and are age and sex dependent (see Haematology reference ranges). Individuals have much tighter normal ranges so that comparison with previous results can be helpful.
Sample Required: 3 ml blood in purple topped container (EDTA)
Blood Film
Manual examination of red cell morphology, platelets and DWCC
Blood films are made only when indicated by either clinical information or by the full blood count findings. If you specifically require a film please request FILM in the large space provided on the haematology / biochemistry form and state the clinical indication eg possible glandular fever.
If malaria is suspected please request malaria examination and specify clinical reason. The clinical data is essential to ensure approproate investigation i.e. a thick blood film is needed.
Sample required: FBP sample, less than 24 hours old.
ESR Sample required: 3ml blood in purple topped container (EDTA) . A separate sample is required from that provided for the FBC.
Reticulocyte count Sample required: 3 ml blood in purple topped container (EDTA) This can be obtained from the sample used for FBC.
Infectious Mononucleosis Slide Test Sample Required: 3 ml blood in purple topped container (EDTA)
A negative result does not exclude a diagnosis of infectious mononucleosis. This can be obtained from the same sample used for FBC.
Kleihauer test. Used to detect presence of red cells containing Hb F. It is used in assessment of feto-maternal haemorrhage in Rhesus negative mothers.
For further details on use of Kleihauer and administration of human anti-D see section on 'Blood bank products'.
Sample required: 3 ml in purple topped tube (EDTA).
Leucocyte Alkaline Phosphatase Score (LAP score)
This test is performed on fresh blood films (without the addition of EDTA) which need to be fixed within 30 minutes of initial preparation. Please discuss with the laboratory when this test can be performed and arrange prompt delivery of fresh blood films to the laboratory.
Samples Required: fresh blood films (see above) . A rack of microscope slides can be requested from the lab for preparation of fresh smears at the bedside.
Plasma viscosity Sample required: 3ml in purple topped container (EDTA). A separate sample is required from that provided for the FBC because test is despatched to BCH for analysis.
Haematinics Serum ferritin, iron profile, serum folate and vitamin B12 levels are assayed in the biochemistry lab.
The investigation of haemolysis is complex and the Consultant Haematologists will advise on appropriate tests for individual cases. Tests are required to confirm the presence of haemolysis and identify the cause.
Tests to demonstrate the presence of haemolysis
Please note: the correct volume of blood is essential for accurate coagulation results.
Coagulation screen
This consists of Prothrombin Time (PT), Activated Partial thromboplastin time (APTT), Thrombin Time (TCT) and Fibrinogen concentration .
A
platelet count is required to complete the screen and
so a FBP should be requested at the same time.
| Indications are: | Investigation
of bleeding or bruising tendency, before needle liver biopsy, ERCP,
renal biopsy or transbronchial biopsy. |
| Monitoring
of massively transfused patients.In suspected disseminated intravascular
coagulation (DIC). |
|
| Before commencing anticoagulant therapy. |
Abnormal tests may be investigated further. The laboratory will phone if another specimen is required.
Samples Required: 4.0 ml in blue topped tube (citrate) + 3 ml in purple topped tube (EDTA)
D-Dimers
In Venous thromboembolism (VTE), D-Dimers have a negative predictive value: i.e. a normal result in a patient with a low clinical probability score helps to rule out the diagnosis VTE.
D-Dimers are useful in confirming disseminated intravascular coagulation
Sample Required: 4.0 ml in blue topped tube (citrate).This can be performed on the sample supplied for coagulation screen
Reptilase time
This test time is not prolonged by heparin and it is used to discriminate a prolonged TCT due to unfractionated heparin from other causes.
Sample required: 4 .0 ml in blue topped tube (citrate). This can be performed on the sample supplied for coagulation screen.
Clotting
Factor assays
Required to diagnose acquired or hereditary factor deficiencies such as
Haemophilia A (Factor VIII deficiency) and haemophilia B (Factor IX deficiency).
Sample
required: 4.0 ml in blue topped tube (citrate). Accurate filling of sample
tube is essential.
These sample are transported to the Coagulation Lab, BCH for testing.
Please discuss with CAH Haematology Lab in advance of testing to arrange
correct time for accurate analysis.
Von
Willebrand disease tests
Testing for VW Antigen, VW activity and factor VIII activity.
Sample required: 2 x 4.0 ml in blue top tube (citrate). Accurate filling of sample tubes is essential. Sample sent to BCH Coagulation Laboratory.
Platelet
Aggregation
This is carried out in the Coagulation section of the Haematology Lab,
BCH. It is essential that fresh samples reach the lab within 1 hour of
venepuncture. Patients must attend the Haemophilia Centre, BCH for venepuncture.
Please telephone the Sister in charge at the Haemophilia Centre to make
an appointment for the patient to attend for testing.
Simplate
Bleeding Time
This
bedside test is used in the investigation of possible bleeding disorders.
It is not useful in predicting surgical bleeding risk.
Please arrange with a Consultant Haematologist or Staff Grade in Haematology.
Inhibitor
Screen
By mixing test plasma with normal plasma the lab can descriminate between
the presence of an acquired inhibitor and clotting factor deficiency.
Useful in identifying cause of isolated prolonged APPT.
Sample required: 4.0 ml in blue top tube (citrate). Can be performed on sample used for coagulation screen.
Lupus Anticoagulant
This
antiphospholipid antibody is clinically associated with venous and arterial
thrombosis and recurrent miscarriage. The term anticoagulant is used because
of prolongation of in - vitro coagulation when the antiphospholipid
antibody is present.
Diagnostic Criteria:
| A
phospholipid-dependent test is prolonged ie APTT or the more sensitive
DRVVT. |
|
| There
is no correction of abnormal test with mixing ie inhibitor present.
|
|
| The
addition of phospholipid corrects the abnormal result. |
|
| A specific factor inhibitor or other coagulopathy is ruled out. |
Sample Required: 2 x 4.0 ml in blue topped tubes (citrate) - Please arrange urgent transport to Haematology Laboratory, CAH. Please note oral anticoagulation invalidates the test for lupus anticoagulant.
DRVVT Result is reported as ratio of test time/control time. Normal Ratio <1.2
In addition a clotted sample should be sent to Immunology for Anti-cardiolipin antibodies.
Screening for inherited Thrombophilia
An increased risk of venous thromboembolism is recognised in patients with deficiencies of anti thrombin III, protein C or protein S, and resistance to activated Protein C.
Who to test Screening for inherited thrombophilia is not routinely advised but may be considered in cases where there is a strong family history, recurrent spontaneous DVT, spontaneous VTE at a young age and where unusual veins such as the axillary vein or mesenteric vein are involved. Testing women of child bearing age may be indicated to assess risk of VTE in a future pregnancy.Please discuss with a Consultant Haematologist.
When to test: samples should be collected at least 3 months after the last thrombotic event and at least 2 weeks after completion of anticoagulant therapy.
Patients should not be tested:
1. during an episode of DVT / PE
2. while on oral anticoagulant therapy
3. during heparin therapy
4. during Pregnancy or up to 3 months postpartum
5. while taking oestrogen preparations
6. under treatment with L-asparaginase
7. if they have nephrotic syndrome, liver disease, DIC or any inflammatory state.
The standard reference ranges do not apply in these situations.
Sample required: 4 x 4.0 ml in blue top tubes (citrate).
Genetic tests for Factor V Leiden (associated with APC Resistance ) and Prothrombin G20210A mutations can be arranged after discussion with a Consultant Haematologist. The tests are performed at the Haematology Lab, BCH.
To complete the thrombophilia screen for arterial or venous disease, check for fasting hyperhomocysteine. Sample required: 3 ml blood in EDTA (purple topped) tube to be sent on ice to Biochemistry for separation of plasma within 1 hour of collection.
All
patients receiving unfractionated or LMWH should have a FBC, coagulation
screen,
U & E and LFT carried out before starting therapy.
Reduce dose of LMWH in severe renal impairment i.e. creatinine clearance < 30 ml / min.
For details on therapy see Medical management guidelines on "anticoagulation in venous thromboembolism".
During treatment monitor FBC and U & E; the risk of heparin induced thrombocytopenia / thrombosis is greatest from day 5 to 10 of therapy. Hyperkalaemia has been reported with heparin therapy.
'HITT
assay for Heparin associated platelet factor 4 antibodies.
Please refer to the medical unit guideline for calculation of the workention
HITT score.
The Consultant Haematologist / Registrar at theHaemophilia Centre, BCH
must be contacted to arrange testing. For full detail see above guideline.
Low molecular weight heparin (LMWH).
The LMWH's have a predictable therapeutic effect and monitoring of prophylactic and treatment doses is not required routinely.
In
the following circumstances monitoring may be advised:
• obese or very thin patients in whom dosing is uncertain
• renal impairment to exclude high levels due to accumulation
• pregnancy, a non-licensed circumstance.
The test used is anti-Xa activity
Sample required: 4.0 ml blood in blue topped tube (citrate)
Peak levels at 2-4 hr after SC injection of therapeutic dose should fall within range 0.4 - 1.0 u/ml.
Standard unfractionated heparin
Monitor APTT 6 hours after the loading dose of IV heparin or a change of infunional dose. The therapeutic range for effective anticoagulation with unfractionated heparin is APTT 1.5 - 2.5 times normal i.e. 50 - 77 secs in Craigavon Hospital.
Sample Required: 4.0 ml blood in blue topped tube (citrate). Send specimens rapidly to the laboratory to allow separation of platelets from plasma within 45 minutes in order to minimize neutralization of in-vitro heparin by platelet factor 4.Consult medical management guidelines on "anticoagulation in venous thromboembolism" for the Target INR and duration of therapy in arterial and venous conditions and guidelines on reversal of warfarin therapy.
Check coagulation screen, FBP and LFT before starting therapy.
Consider tests for antiphosphlipid antibody in high risk individuals before starting warfarin.
Therapeutic warfarin doses for individual patients differ widely. Many drugs interact with warfarin. Close control is therefore essential. The prothrombin time should be checked prior to commencement of warfarin as patients with prolonged times will be very sensitive to warfarin.
Warfarin dosage is adjusted according to the INR (International Normalised Ratio) which is calculated from the test and control Prothrombin times .
Sample
Required: 4.0 ml blood in blue topped tube (citrate)
Back
to Top
For full details refer to the Hospital Blood Transfusion Policy (on SHSCT Intranet). The transfusion of incompatible blood may prove fatal; errors in identification of either patient or sample are chiefly responsible and are preventable. Such errors include taking a crossmatch specimen from the wrong patient and inadvertently checking the details of crossmatched blood against those of a different patient. Please remember that it is the responsibility of the individual taking the blood sample to ensure correct identification between specimen and patient and sign the request form on the back appropriately.
First
name, Surname, DOB, and Hospital Unit Number essential for cross-matched
samples, or address for group and screen.
(All non-conforming samples will be rejected without exception).
Sex is essential on Infant sample.
For further information see sections on 'Request forms' and 'specimen collection'.
Reporting of Blood Transfusion Results
These will be delivered to the requesting department as early as possible. Blood Groups are not given over the telephone unless to the requesting Medical Staff concerned.
When any potentially significant red cell antibodies are detected in transfusion samples received from in-patients, the requesting doctor or, if not available, the nurse in charge of the ward will be informed of the result, as soon as possible by telephone,
Elective Surgery
A blood tariff for elective surgery has been agreed for most surgical specialties. If you are requesting more than the agreed tariff please indicate why and discuss with the laboratory if necessary. In the light of changing surgical procedures this tariff is under review.
Group and Screen or Group Screen and Crossmatch
In order to safeguard patients, the laboratory routinely requires a minimum of 2 blood grouping results to be available on the computer database before any group specific blood component can be issued. The laboratory will inform clinicians when a second sample is needed.
Sample Required: 6 mls of blood in a pink topped tube with white insert (EDTA). This should reach the laboratory by 1030 hours at the latest for an afternoon transfusion or by 1430 for transfusion the following day.
Requests in excess of 4 units of blood require 2 x 6 ml in pink topped tubes with white insert (EDTA).
Ante-natal samples
These samples are processed by the NI Blood Transfusion Service, Belfast City Hospital . For details of samples required and results, please contact directly the ante-natal department, NIBTS.
Blood for Babies less than 6 weeks old
Samples required: Group and Screen sample from mother and EDTA microtube sample from infant.
Where the mother has not been grouped and screened in the past these investigations must be carried out prior to transfusion of the infant, or issue of Anti-D to the mother whose baby is Rhesus positive.
When
the mother is found to be ABO compatible with her infant and has Rhesus
or Atypical antibodies as a result of her pregnancy a full crossmatch
must be carried out with donor blood and maternal serum.
Exchange Transfusion
Plasma reduced whole blood from CMV negative donors is usually specially prepared. Anticipation of the need for exchange transfusion helps minimise the delay caused when suitable blood is not immediately available.
Emergency Blood Transfusion (use of uncrossmatched blood).
In
an emergency a short crossmatch procedure means that compatible blood
can be issued to the patient within 30 minutes of receipt of the crossmatching
sample.
In the event of an emergency uncrossmatched blood of the same ABO/Rh group
as the patient may be issued.
In the event of an extreme emergency uncrossmatched ORh negative blood may be transfused but this must only be at the discretion of the medical officer. Full details of any patient receiving this blood must be sent, together with the donor unit number, to the Blood Bank immediately.
Emergency Blood and its Location .
In cases of extreme emergency a limited amount of uncrossmatched blood is available at the following locations:
Craigavon Area Hospital Blood Bank (Theatre/Maternity use)
2
Units O Rh Negative blood in issue Bank. Specifically labelled:
EMERGENCY BLOOD FOR THEATRE/MATERNITY USE ONLY.
If any of these units are used in an extreme emergency the Blood Bank at Craigavon Area Hospital must be informed immediately by telephone of the DONOR UNIT NUMBER of the Blood Pack(s) and the FULL IDENTIFICATION OF PATIENT receiving the blood.
The supply of emergency units of blood will be replaced.
NB: FAILURE TO CARRY OUT THIS PROCEDURE COULD RESULT IN BLOOD NOT BEING AVAILABLE IN EMERGENCY SITUATIONS
If blood is required in an emergency telephone 02838 612666 or after hours and at weekends and Bank Holidays contact BMS on call, telephone number : 07801 458703
A transfusion reaction should be suspected in patients developing urticaria, fever, loin pain or bronchospasm whilst being transfused with blood.
The transfusion should be stopped. Patient identity and the blood label should be checked.
The following should be sent to the blood bank :
• The remainder of the donor blood unit
• 2 x 6.0 ml in pink topped tubes with white insert (EDTA).
In Addition
- The first urine passed should be checked for haemoglobinuria.
- Consider checking FBP, U&E , LFT, Coagulation, Blood culture, Blood gas.
If the clinical situation necessitates continuing transfusion the advice of the Haematologist on call should be sought.
If ABO incompatible blood has been given steps must be taken to maintain blood pressure and urine output. The problem should be notified to the Consultant Haematologist and the Intensive care Anaethetist on call.
Most febrile reactions are due to white cell antibodies. The incidence of this has reduced with the introduction of leucocyte filtration of all units of donor blood. Patients with a history of more than one febrile reaction may be helped by pre-medication with paracetamol, chlorpheniramine and hydrocortisone. If there are continuing problems please discuss with a Consultant Haematologist.
All adverse events during transfusions must be reported immediately by telephone to blood bank. An adverse event form must be completed and forwarded to blood bank. The incident will be fully investigated by blood bank staff and the haemovigilance practitioner.
Massive Transfusion
This leads to coagulation factor and platelet dilution. This should be monitored by a platelet count and coagulation screen in any patient who receives more than 6 units of blood within 24 hours. The Consultant Haematologist on call can advise on the need for platelet and coagulation factor replacement.Blood
-all
units of blood issued are leucocyte poor red cell concentrates with optimal
additive solution. We are unable to supply whole blood and fresh blood.
Irradiated Blood Products
Platelets - These are not stocked in the Hospital Blood Bank but can be obtained from the Regional Blood Transfusion Service in about 1½ hours. They may be stored for 48 hours in the Hospital Blood Bank at Craigavon Area Hospital not on the ward. Please discuss with the Consultant Haematologist as accurate diagnosis of thrombocytopaenia may be required. If a platelet transfusion reaction is suspected send samples as for suspected red cell transfusion reaction.
Platelets are usually given over 30 minutes and as soon as possible after arrival. Platelets are issued as a therapeutic dose prepared from 4/5 donations. Platelets should never be kept for a prolonged period on a ward or in theatre.
Fresh Frozen Plasma
This provides useful replenishment of coagulation factors in massive transfusion and DIC. Thawing takes approximately 30 minutes. Thawed plasma can be stored for up to 24 hours but should be transfused a.s.a.p. For best clinical results, plasma should be transfused within two hours of thawing.
FRESH FROZEN PLASMA WILL ONLY BE ISSUED IN BATCHES OF 2 UNITS PER REQUEST, TO AVOID WASTAGE OF SCARCE STOCKS.
Human Anti-D
Anti-D is given to all rhesus negative women who do not already have anti-D antibodies after termination, miscarriage or antipartum haemorrhage and after delivery to rhesus negative mothers with rhesus positive babies.
| Dose: | before 20 weeks 250 iu |
| after 20 weeks 500 iu. |
Once rhesus negative mothers have delivered, a maternal specimen should be sent along with the cord blood specimen from their baby for rhesus testing. If the baby is rhesus positive and the mother rhesus negative anti-D is given to the mother. A Kleihauer test is carried out to detect significant feto maternal haemorrhage following which further anti-D may be advised.
Sample required for Kleihauer Test: 3 ml blood in purple topped tube (EDTA).
It is recommended that following events during pregnancy prior to 20 weeks gestation 250 iu of anti-D immunoglobulin is given. This is increased to 500 units for events later than 20 weeks gestation. A Kleihauer Test should also be undertaken following events later than 20 weeks gestation as a larger dose of anti-D immunoglobulin may be required.
The results of the estimation of feto maternal bleeding are given as volume of foetal bleed.
Anti-D immunoglobulin should be given to all rhesus D negative women who give birth to an infant who is shown to be rhesus D positive or if the group of the infant cannot be determined. A dose of 500 iu of anti-D immunoglobulin should be given within 72 hours of delivery.
In a small proportion of cases the Kleihauer Test will identify a requirement for a larger dose. Additional anti-D immunoglobulin is administered at a rate of 500 IU per 4ml of foetal bleed.
Follow-up of a feto maternal haemorrhage of greater than 4 mls is essential with repeat Kleihauer testing at 48 hour intervals. Adminstration of appropriate doses of additional anti-D immunoglobulin if foetal red cells persist will be required
Cryoprecipitate
Now that factor VIII concentrates are preferred in the treatment of haemophilia and Von Willebrands disease, cryoprecipitate is mainly used as a source of fibrinogen in cases of defibrination identified on coagulation screening. Thawing and pooling takes 30 minutes. Transfuse immediately over 30-60 minutes.
Novo 7
Used in cases of life threatening haemorrhage unresponsive to all other methods of controlling haemorrhage and after discussion with a Consultant Anaethetist and Haematologist, eg catastrophic post partum haemorrhage.
Dose 90 microgram / kg body weight as single treatment.
Limited stock in blood bank.
OCTAPLEX
This is the prothrombin complex concentrate held in blood bank for the rapid reversal of warfarin in the event of major haemorrhage.
| Dose: | 30 iu/kg | INR > 4 |
| 15 iu/kg | INR < 4 |
It is essential to stop warfarin and give vitamin K 5 mg by slow intravenous injection.
Monitor INR and APTT immediately and at 4 hours.
Consult
Medical management guidelines for full details and discuss with Consulant
haematologist.
Back
to Top
Medical Management Guidelines
Screening for genetic haemachromatosis
Introduction
1 |
Measurement of iron profile (ie transferrin saturation) and ferritin are the primary tests for population screening. |
|
2 |
At present, genetic testing cannot be justified at the first level of screening*. It would not be possible to provide those individuals, genetically at risk, with a reliable estimate of the likelihood of developing clinical features of Haemochromatosis. |
|
3 |
The Genetic test ( HFE gene analysis) is used to: |
|
|
3.1 |
Confirm the diagnosis in cases of suspected iron overload ie those with elevated transferrin saturation. |
3.2 |
Investigate
families of patients with Haemochromatosis (partner, parents, siblings
and children). These individuals should have tests for iron profile, ferritin and gene analysis. |
|
* BCSH guidelines February 2000 on Genetic Haemochromatosis
Samples needed for the tests
1 |
On
a biochemistry form request iron and ferritin. |
2 |
If
transferrin saturation is greater than 50%, repeat the measurement
on a fasting sample. |
3 |
On
a biochemistry form request HFE gene You must specify reason is Haemochromatosis The doctor must sign this form (as confirmation that the patient consents to a genetic test) Send 4 x purple top (EDTA/FBP) bottles Mark form for attention of Tissue Typing Lab , Belfast City Hospital (it will be forwarded from CAH lab to BCH lab) |
Back to Top
TESTS,
SAMPLES AND TURNAROUND TIMES
In
the following table EDTA refers to the purple topped tube, sodium citrate
to the blue topped tube, clotted blood to the red topped tube, green topped
tube to the lithium heparin. When the transfusion tube, with the pink
top and white insert, is required, this is specified. Please arrange tests
as required in advance with the lab. If urgent results are required please
inform lab staff and they will try to accommodate your request.
| Test | Sample Required | Turnaround Time |
| Full blood count | EDTA | same day |
| ESR | EDTA | same day |
| Blood film | EDTA | same day |
| Reticulocytes | EDTA | same day |
| Plasma viscosity | EDTA | same day |
| Infectious mononucleosis | EDTA | same day |
| *Leucocyte
alkaline phosphatase score |
fresh
blood |
same
day film **special handling of sample is needed, please refer to Haematology Lab ext. 2665 / 2705 |
| Sickle cell rapid | EDTA | same day test |
| Haptoglobin | Clotted blood | 72 hours |
| Plasma haemoglobin | RVH Haematology Laboratory | |
| Haemoglobin | ||
| - electrophoresis | EDTA | RVH Special Investigation Lab |
| - H preparation | EDTA | |
| - stability | EDTA | |
| Direct antiglobulin test | EDTA | same day |
| Donath Landsteiner antibody test | pink with white insert/EDTA | same day |
| G6PD deficiency screening test | EDTA | RVH |
| *Urinary haemosidern | Universal container | same day |
| *Bone Marrow Aspirate | Sample bottles from Haem Lab in 'BM pack' | one week |
| *Bone Marrow Trephine | BM pack | two week |
APTT |
Sodium Citrate | same day |
INR (Warfarin control) |
Sodium Citrate | same day |
| Coag screen | Sodium Citrate | same day |
| D dimers | Sodium Citrate | same day |
| *Lupus anticoagulant | Sodium Citrate x 2 | one
week **special handling of sample is needed, please refer to Haematology Lab ext. 2665 / 2705 |
| *Factor VIIIC | Sodium Citrate x 2 | BCH Coagulation Lab |
| *Factor IXC | Sodium Citrate x 2 | BCH Coagulation Lab |
| *Other factor assays | Sodium Citrate x 2 | BCH Coagulation Lab |
| *Inherited Thrombophilia Sodium screen | Citrate x 3 | one
week If referred to Reference Laboratory - Several weeks. |
| *Platelet aggregation | Sodium Citrate x 4 | 1 day BCH Coagulation Lab if referred to Reference Lab - several weeks. **special handling of sample is needed, please refer to Haematology Lab ext. 2665 / 2705 |
| Inhibitor screen | Sodium Citrate | same day |
| Reptilase time | Sodium Citrate | same day |
| Test | Container | Turnaround Time |
| Seminal Analysis | clean sterile container | same day |
| Cross-match | EDTA ( pink top tube) | same day |
| Blood Group + antibody screen | EDTA (pink top tube) | same day |
| Antibody Identification | EDTA (pink top tube) | same day (if possible, or following day at latest) |
| Kleihauer | (EDTA) | within 72 hours |
| Red Cells (RBC) x 10 12 /l | Males
|
4.0
- 5.5 3.8 - 5.5 |
| Haemoglobin (Hb) |
|
g/dl
13.0 - 18.0 11.5 - 16.0 |
| Haemocrit (HCT - packed cell volume) | Males Females |
0.40
- 0.52 0.37 - 0.47 |
| Mean cell volume (MCV) fl | . | 80 - 99 |
| Mean Cell Haemoglobin (MCH)pg | . | 27.0 - 32.0 |
| Mean
cell Haemoglobin Concentration (MCHC) |
. | g/dl
30.0 -36.0 |
| Platelets x 10 9 /l | . | 150 - 450 |
| Reticulocytes | . | 0 - 2% |
| Leucocytes
(WCC) x 10 9 /l |
. | 4.0
-11.0 x 10 9/l |
| Differential Leucocyte Count (automated Diff or manual Diff) | % | x 10 9 /l |
| Neutrophils Lymphocytes Monocytes Eosinophils Basophils |
45
-70 25 - 40 1 -13 1 - 6 1 - 2 |
1.8
- 7.7 1.0 - 4.4 0.04 - 1.4 0.04 - 0.66 <0.1 |
| Erythrocyte sedimentation Rate (ESR) mm in 1 hour at 20°C ± 3°C (upper limits) | ||
| Male ESR |
0 - 10 years 1 1 - 50 years 5 1 - 60 years > 61 years |
0
- 10mm 0 - 10mm 0 - 12mm 0 - 30 mm |
| Female ESR | 0
- 10 years 11 - 50 years 51 - 60 years > 61 years |
0
- 12 mm 0 - 12 mm 0 - 19mm 0 - 35 mm |
| Back to Top | ||
Coagulation |
||
| Prothrombin time | . | 9 - 13 seconds |
| Activated Partial thromboplastin time (APTT) | . | 23 - 31 seconds |
| Thrombin Time | . | 14 - 18 seconds |
| Fibrinogen | . | 1.8 - 4.0 g/l |
| D-Dimer | . | <280ng/ml |
| Antithrombin III | . | 80 - 120% |
| Protein C | . | 70 - 130% |
| Protein S | . | 70 - 130% |
| Activated Protein C Resistance | . | |
| Ratio (APC-R) | . | >2.00 |
Dilute Russell's Viper |
. | |
| Venom Time (DRVVT) - Ratio | . | <1.20 |
| Factor II | . | 50% - 150% |
| Factor V | . | 50 - 150% |
| Factor VII | . | 50 -150% |
| Factor X | . | 50 -150% |
| Factor VIII | . | 50 - 150% |
| Factor IX | . | 50 - 150% |
| Factor XI | . | 50 - 150% |
| Factor XII | . | 50 - 150% |
| Von willebrand antigen | . | 60 - 200% |
| Von willebrand activity | . | 60 -150% |
| Haematinics Serum folate Serum vitamin B12 Serum ferritin - males, females |
. | See Clinical Biochemistry |
Miscellaneous |
||
Eythropoietin |
. | 2.5
-10.5 mlu/ml |
| Back to Top | ||
HAEMATOLOGY REFERENCE RANGES FOR CHILDREN |
||
| Red Cells (RBC) x 1012/l | . | . |
| 3 months | . | 3.5 - 5.5 |
| 3-6 years | . | 4.0 - 5.5 |
| Haemoglobin (Hb) | . | g/dl |
| 1 st week | . | 12.0 - 20 |
| 3 months | . | 10 - 17 |
| 3-6 years | . | 9.5 - 14.0 |
| Haemocrit (HCT - packed cell volume) | . | |
| 3 months | . | 0.35 - 0.50 |
| 3-6 years | . | 0.30 - 0.42 |
Mean Cell Volume (MCV) fl |
. | |
| 1st week | . | 96 - 120 |
| 3 months | . | 80 - 95 |
| 3-6 years | . | 80 - 95 |
| Mean cell Haemoglobin (MCH) pg | . | |
| 3 months | . | 32 - 34 |
| 3-6 years | . | 27 - 32 |
| Mean cell Haemoglobin Concentration | . | g/dl |
| Cord - 6 years | . | 30 - 36 |
| Reticulocytes Cord 3 months Platelets x 10 9/l Cord - 2 nd week 2 nd week and over Leucocytes x 10 9/l Cord - 3 rd day 4 th day - 4 th year 4-7 years |
. |
|
| Back to Top. | ||
Differential Leucocyte count (automated or manual) |
||
| X 10 9 /l | x 10 9 /l | |
| Cord -3 rd day | 4 th day -4 th year | |
| Neutrophils Lymphocytes Monocytes Eosinophils Basophils |
1.5
- 7.0 2.0 - 5.0 0.3 - 1.1 0.2 - 2.0 <0.1 |
2.0
- 6.0 5.8 - 8.5 0.7 - 1.5 0.3 - 0.8 <0.1 |
| Back to Top | ||
Andrology Normal Ranges |
||
| Volume | . | > 2.0 ml |
| Count | . | > 20 x 10 6/ml |
Motility
rapid |
. | >
25% > 50% |
| Morphdogy | . | < 80% abnormal forms |
| pH | . | 7.2 - 7.8 |
| Martest | . | Negative |